Our Commitment to Science
When you think about it, a company that combines Phase I-IV clinical capabilities with state-of-the-art, highly-automated bioanalytical services is one of the most efficient drug development models. Entire programs can be conducted in house, with samples collected in the clinical facilities seamlessly handed off to the lab for analysis.
CEDRA Corporation offers a full range of clinical and bioanalytical services ranging from methods development to final report preparation, including capabilities such as our Specialized Studies Unit for complex studies requiring meticulous planning and monitoring, our newly-integrated Ligand Binding Assay lab, and our connection to large-scale, worldwide clinical trials through our parent corporation, WCT.